Q8IVG9 (HUNIN_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 60.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Putative humanin peptide | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Reference proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 24 AA. |
| Sequence status | Complete. |
| Protein existence | Uncertain |
General annotation (Comments)
| Function | Plays a role as a neuroprotective factor. Protects against death induced by multiple different familial Alzheimer disease genes and beta amyloid proteins in Alzheimer disease. Suppresses apoptosis by binding to BAX and preventing the translocation of BAX from the cytosol to mitochondria. Binds to IGFBP3 and specifically blocks IGFBP3-induced cell death Induces chemotaxis of mononuclear phagocytes via FPR2. Reduces the aggregation and fibrillary formation by suppressing the effect of APP on mononuclear phagocytes and acts by competitively inhibiting the access of FPRL1 to APP. Ref.1 Ref.2 Ref.4 Ref.7 Ref.8 |
| Subunit structure | |
| Subcellular location | |
| Tissue specificity | Expressed in the heart, skeletal muscles, kidney and liver. Lesser but significant expression is observed in the brain and the gastrointestinal tract. Expressed in the AD brain, where it is found in some of the large intact neurons of the occipital lobes and small and round reactive glial cells in the hippocampus. Ref.1 Ref.5 Ref.9 |
| Induction | Release is regulated by intracellular mechanism. The intracellular level is regulated by TRIM11 through proteasome-mediated degradation. Ref.9 |
| Domain | Largely unstructured in aqueous solution. Ref.10 |
| Sequence similarities | Belongs to the humanin family. |
| Caution | Product of a dubious CDS prediction. The sequence shown is derived from a portion of the mitochondrial MT-RNR2 gene (Ref.5). The existence of this protein sequence in vivo is possibly dubious. No mechanism has been demonstrated for its production and translocation to the cytoplasm and extracellular space. If translated in the mitochondrion rather than the cytoplasm, the usage of the mitochondrial genetic code would lead to the production of a shorter peptide lacking the last three C-terminal residues. An alternative possibility is that the true physiological humanin peptide is encoded by one or more of several nuclear loci apparently derived from MT-RNR2 (Ref.9). |
Ontologies
| Keywords | |
|---|---|
| Biological process | Apoptosis |
| Cellular component | Cytoplasm Secreted |
| Technical term | 3D-structure Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | apoptotic process Inferred from electronic annotation. Source: UniProtKB-KW cellular iron ion homeostasisNon-traceable author statement PubMed 15567815. Source: UniProtKB leukocyte chemotaxisInferred from direct assay Ref.8. Source: UniProtKB negative regulation of apoptotic processInferred from direct assay PubMed 11327724PubMed 15661735PubMed 15661737. Source: UniProtKB |
| Cellular_component | extracellular region Inferred from direct assay Ref.1. Source: UniProtKB mitochondrionInferred from direct assay PubMed 15567815. Source: UniProtKB perinuclear region of cytoplasmInferred from direct assay PubMed 15619032. Source: UniProtKB |
| Molecular_function | receptor antagonist activity Inferred from direct assay Ref.8. Source: UniProtKB |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||
Molecule processing | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Peptide | 1 – 24 | 24 | Putative humanin peptide | PRO_0000044146 | |||||||||
Regions | |||||||||||||
| Region | 3 – 19 | 17 | Sufficient for neuroprotective activity | ||||||||||
| Compositional bias | 9 – 12 | 4 | Poly-Leu | ||||||||||
Experimental info | |||||||||||||
| Mutagenesis | 1 – 6 | 6 | Missing: No effect on binding to BAX. Ref.2 Ref.7 | ||||||||||
| Mutagenesis | 1 – 3 | 3 | Missing: Abolishes neuroprotective activity. Ref.4 | ||||||||||
| Mutagenesis | 1 – 2 | 2 | Missing: No effect on neuroprotective activity. | ||||||||||
| Mutagenesis | 3 | 1 | P → A: Abolishes neuroprotective activity. Ref.4 | ||||||||||
| Mutagenesis | 4 – 6 | 3 | RGF → AGA: Potentiates neuroprotective activity. Ref.2 Ref.4 | ||||||||||
| Mutagenesis | 6 | 1 | F → A: Abolishes binding to IGFBP3. Ref.2 | ||||||||||
| Mutagenesis | 8 | 1 | C → A, D, E, F, G, I, L, M, N, Q, S, T, V, W or Y: Abolishes neuroprotective activity. Ref.4 Ref.7 | ||||||||||
| Mutagenesis | 8 | 1 | C → H: Significantly reduces the neuroprotective activity. Ref.4 Ref.7 | ||||||||||
| Mutagenesis | 8 | 1 | C → K or R: No effect on the neuroprotective activity. Ref.4 Ref.7 | ||||||||||
| Mutagenesis | 8 | 1 | C → P: Abolishes neuroprotective activity and interaction with BAX. Ref.4 Ref.7 | ||||||||||
| Mutagenesis | 9 | 1 | L → A: Abolishes neuroprotective activity. Ref.4 Ref.7 | ||||||||||
| Mutagenesis | 9 | 1 | L → R: Abolishes binding to BAX. Ref.4 Ref.7 | ||||||||||
| Mutagenesis | 12 | 1 | L → A: Abolishes neuroprotective activity. Ref.4 | ||||||||||
| Mutagenesis | 13 | 1 | T → A: Abolishes neuroprotective activity. Ref.4 | ||||||||||
| Mutagenesis | 14 | 1 | S → A: Abolishes neuroprotective activity. Ref.4 | ||||||||||
| Mutagenesis | 14 | 1 | S → G: Potentiates neuroprotective activity. Ref.4 | ||||||||||
| Mutagenesis | 19 – 24 | 6 | Missing: Abolishes neuroprotective activity. Ref.4 | ||||||||||
| Mutagenesis | 19 | 1 | P → A: Abolishes neuroprotective activity. Ref.4 | ||||||||||
| Mutagenesis | 20 – 24 | 5 | Missing: No effect on neuroprotective activity. Ref.4 | ||||||||||
Secondary structure | |||||||||||||
Helix Strand Turn | |||||||||||||
| Helix | 4 – 15 | 12 | |||||||||||
| Beta strand | 18 – 21 | 4 | |||||||||||
Sequences
References
| « Hide 'large scale' references | |
| [1] | "A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta." Hashimoto Y., Niikura T., Tajima H., Yasukawa T., Sudo H., Ito Y., Kita Y., Kawasumi M., Kouyama K., Doyu M., Sobue G., Koide T., Tsuji S., Lang J., Kurokawa K., Nashimoto I. Proc. Natl. Acad. Sci. U.S.A. 98:6336-6341(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY. Tissue: Brain. |
| [2] | "Interaction between the Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis." Ikonen M., Liu B., Hashimoto Y., Ma L., Lee K.W., Niikura T., Nishimoto I., Cohen P. Proc. Natl. Acad. Sci. U.S.A. 100:13042-13047(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH IGFBP3, MUTAGENESIS OF PHE-6. |
| [3] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [4] | "Detailed characterization of neuroprotection by a rescue factor humanin against various Alzheimer's disease-relevant insults." Hashimoto Y., Niikura T., Ito Y., Sudo H., Hata M., Arakawa E., Abe Y., Kita Y., Nishimoto I. J. Neurosci. 21:9235-9245(2001) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, MUTAGENESIS OF 1-MET-ALA-2; 1-MET--PRO-3; PRO-3; 4-ARG--MET-6; CYS-8; LEU-9; LEU-12; THR-13; SER-14; PRO-19; 19-PRO--ALA-24 AND 20-VAL--ALA-24. |
| [5] | "Evidence for in vivo production of Humanin peptide, a neuroprotective factor against Alzheimer's disease-related insults." Tajima H., Niikura T., Hashimoto Y., Ito Y., Kita Y., Terashita K., Yamazaki K., Koto A., Aiso S., Nishimoto I. Neurosci. Lett. 324:227-231(2002) [PubMed] [Europe PMC] [Abstract] Cited for: EVIDENCE OF IN VIVO EXPRESSION, TISSUE SPECIFICITY. Tissue: Brain. |
| [6] | "A tripartite motif protein TRIM11 binds and destabilizes Humanin, a neuroprotective peptide against Alzheimer's disease-relevant insults." Niikura T., Hashimoto Y., Tajima H., Ishizaka M., Yamagishi Y., Kawasumi M., Nawa M., Terashita K., Aiso S., Nishimoto I. Eur. J. Neurosci. 17:1150-1158(2003) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH TRIM11, SUBCELLULAR LOCATION. |
| [7] | "Humanin peptide suppresses apoptosis by interfering with Bax activation." Guo B., Zhai D., Cabezas E., Welsh K., Nouraini S., Satterthwait A.C., Reed J.C. Nature 423:456-461(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH BAX, SUBCELLULAR LOCATION, MUTAGENESIS OF 1-MET--PHE-6; 18-LEU--ALA-24; CYS-8 AND LEU-9. |
| [8] | "Humanin, a newly identified neuroprotective factor, uses the G protein-coupled formylpeptide receptor-like-1 as a functional receptor." Ying G., Iribarren P., Zhou Y., Gong W., Zhang N., Yu Z.-X., Le Y., Cui Y., Wang J.M. J. Immunol. 172:7078-7085(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [9] | "Evidence for potential functionality of nuclearly-encoded humanin isoforms." Bodzioch M., Lapicka-Bodzioch K., Zapala B., Kamysz W., Kiec-Wilk B., Dembinska-Kiec A. Genomics 94:247-256(2009) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY, INDUCTION. |
| [10] | "Solution structure of humanin, a peptide against Alzheimer's disease-related neurotoxicity." Benaki D., Zikos C., Evangelou A., Livaniou E., Vlassi M., Mikros E., Pelecanou M. Biochem. Biophys. Res. Commun. 329:152-160(2005) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR, DOMAIN. |
| [11] | "Solution structure of Ser14Gly-humanin, a potent rescue factor against neuronal cell death in Alzheimer's disease." Benaki D., Zikos C., Evangelou A., Livaniou E., Vlassi M., Mikros E., Pelecanou M. Biochem. Biophys. Res. Commun. 349:634-642(2006) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR OF MUTANT GLY-14. |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AY029066 mRNA. Translation: AAK50430.1. BE899497 mRNA. No translation available. | ||||||||||||||||||
| IPI | IPI00383412. | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||
| ProteinModelPortal | Q8IVG9. | ||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| MINT | MINT-265682. | ||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| GeneCards | GCMTP001674. | ||||||||||||||||||
| HGNC | HGNC:7471. MT-RNR2. | ||||||||||||||||||
| MIM | 606120. gene. | ||||||||||||||||||
| neXtProt | NX_Q8IVG9. | ||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||
| Reactome | REACT_111102. Signal Transduction. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| Genevestigator | Q8IVG9. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Other | |||||||||||||||||||
| EvolutionaryTrace | Q8IVG9. | ||||||||||||||||||
| NextBio | 35541109. | ||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||
Entry information
| Entry name | HUNIN_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q8IVG9 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
